Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.

@article{Smith2010IndividualizingTI,
  title={Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.},
  author={Robert J. Smith and David Matthew Nathan and Silva Arslanian and Leif Groop and Robert A. Rizza and Jerome I. Rotter},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2010},
  volume={95 4},
  pages={1566-74}
}
OBJECTIVE Type 2 diabetes is heterogeneous in its clinical features, pathogenesis, and predisposing or causal genetic factors. This report examines what is known and what needs to be learned about the potential to individualize glycemic therapies in type 2 diabetes, based on phenotypes and genotypes. PARTICIPANTS A 29-member international working group with expertise in diabetes epidemiology, physiology, genetics, clinical trials, and clinical care participated in formal presentations and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…